The Lancet

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

The Lancet
Mar 29, 2025, 16:53 | Blog
Evolution and trajectory of B-cell targeted therapies in rheumatic diseases
The Lancet shared an article by Lucy Marie Carter, et al on X: "New treatments such…
Mar 29, 2025, 13:57 | Blog
Introducing The Lancet Obstetrics, Gynaecology, and Women’s Health Journal - The Lancet
The Lancet shared a post on X: "Introducing The Lancet Obstetrics, Gynaecology, and Women’s Health,…
Mar 24, 2025, 13:28 | Blog
The responsibility of health - The Lancet’s new article on social determinants of health
The Lancet shared an article Sandy Tubeuf and colleagues authored on X: "Social determinants of health…
Mar 11, 2025, 13:12 | Science
Patrick Forde: PD-1 VEGF bispecific doubles PFS in 1st line advanced NSCLC
Patrick Forde, Professor at Johns Hopkins University and Co-Director of the Division of Upper Aerodigestive…
Mar 5, 2025, 09:15 | Career
Zoë Mullan: The Lancet Group will launch an open-access journal dedicated to Africa
Zoë Mullan, Editor-in-Chief of The Lancet Global Health and I and D Lead for The Lancet…
Mar 3, 2025, 10:19 | Blog
Zoë Mullan: The latest issue of The Lancet Global Health
Zoë Mullan, Editor-in-Chief of The Lancet Global Health and I & D Lead for The…
Feb 21, 2025, 11:40 | Insight
Zoë Mullan: The launch of our much-anticipated Commission on medical oxygen security
Zoë Mullan, Editor-in-Chief of The Lancet Global Health and I&D Lead for The Lancet Group, shared…
Feb 17, 2025, 10:12 | Blog
Zoë Mullan: Statement in response to recent US executive orders
Zoë Mullan, Editor-in-Chief of The Lancet Global Health and I&D Lead for The Lancet Group,…
Feb 7, 2025, 08:14 | Science
New analyses of global variations in Lung Cancer incidence - IARC/ WHO
IARC - International Agency for Research on Cancer / World Health Organization shared an article…
Feb 6, 2025, 16:18 | Science
Raymond Chan: Shared care between acute care and GPs in primary care
Raymond Chan, Deputy Vice-Chancellor for Research at Flinders University, shared his recent article on LinkedIn:…
Feb 6, 2025, 15:12 | Blog
Pat Price: Taking our campaign directly to Parliament
Pat Price, Clinical Oncologist, Chair of Radiotherapy UK Charity and co-founder of the Global Coalition…
Feb 4, 2025, 09:19 | Science
A major milestone in the Nepal’s efforts towards the elimination of cervical cancer - The Lancet
The Lancet shared an article by Durga Neupane, et al. on X: "Nepal is set…
Feb 2, 2025, 00:59 | Blog
The benefits and challenges of cancer registries in global cancer care - The Lancet
The Lancet shared a post on X: "Urgent action is needed to scale-up cancer prevention…
Jan 25, 2025, 03:54 | Insight
Chiaojung Jillian Tsai: An outstanding review/editorial on radiotherapy toxicities
Chiaojung Jillian Tsai, Lead of the Allan and Ruth Kerbel Palliative RT and Oligomet Program…
Jan 20, 2025, 20:08 | Blog
The Lancet Highlights Dangers of Disinformation in Health
The Lancet Group posted the following on LinkedIn: “‘Health in the age of disinformation.’ Read…
Jan 20, 2025, 13:23 | Science
Fabio Ynoe de Moraes: Addressing the Global Cancer Care Gap - Radiotherapy Access Insights
Fabio Ynoe de Moraes, Associate Professor at Queen’s University, posted on LinkedIn about recent paper…
Jan 20, 2025, 13:05 | Science
Armando Orlandi: The Lancet warns how health misinfo spreads faster in digital age!
Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, posted on X: "Cowabunga! Riding Breast…
Jan 16, 2025, 09:12 | Science
Erman Akkus: TACE plus+ treatments in Hepato-Cellular Carcinoma
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "TACE plus+…
Jan 13, 2025, 13:54 | Science
Nina Niu Sanford: LEAP-012 on Intermediate risk HCC by Masatoshi Kudo et al.
Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s…
Jan 6, 2025, 14:24 | Science
New Insights from the EUROPA trial by Icro Meattini et al.
Kristina Jankovic, Medical Oncology Resident at the University Clinical Center Niš, shared a recent article…
Jan 2, 2025, 11:24 | Blog
Karen Knudsen: Kicking off Cervical Cancer Awareness Month
Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society, posted…
Dec 30, 2024, 11:56 | Science
Anirban Maitra: The highest cited publication overall is a review on Pancreatic Cancer
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…
Dec 29, 2024, 11:57 | Blog
Michael Hofman: A highlight of my year
Michael Hofman, Nuclear Medicine Physician at Melbourne’s Peter MacCallum Cancer Centre and Director of ProsTic,…
Dec 27, 2024, 17:02 | Insight
Toni Choueiri: Top 10 GU Bladder/Kidney Cancer Trials for 2024
Toni Choueiri, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, shared…
Dec 21, 2024, 04:52 | Insight
Do national cancer control plans address care and research for children and AYAs - SIOP
SIOP Europe, the European Society for Paediatric Oncology (SIOPE) shared a post on LinkedIn, about…
Dec 19, 2024, 23:16 | Blog
A. Claudia Schafer: Proud to share that I have received the 2024 STM Journal Elsevier Award
A.Claudia Schafer, Editor In Chief at EClinical Medicine published by The Lancet and Senior Editor…
Dec 16, 2024, 11:41 | Career
Aruni Ghose: Starting a new position as a research fellow at The Lancet Oncology Commission
Aruni Ghose, Chief Medical Officer at OncoFlow and Internal Medicine Resident at Barts Health NHS…
Dec 4, 2024, 09:54 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024
Starting on August 26, in honor of Women’s Equality Day in the United States, which…
Dec 2, 2024, 10:01 | Blog
Women, Power, and Cancer: my latest interview with ecancer - Ophira Ginsburg
Ophira Ginsburg, the Senior Scientific Officer and Senior Advisor for Clinical Research at the US…
Nov 27, 2024, 13:29 | Insight
Richard Sullivan: The State of Global Cancer Surgery from Political and Equity Perspectives
Richard Sullivan, Professor of Cancer and Global Health at King’s College London, shared his recent…
Nov 18, 2024, 08:15 | Blog
Vania Wisdom: Inspiring day at the Houses of Parliament during London Global Cancer Week
Vania Wisdom, Senior Executive Editor and Oncology Ambassador at The Lancet, shared a post on…
Nov 17, 2024, 23:33 | Insight
Nirmala Bhoo Pathy: Started the London Global Cancer Week at The Lancet office
Nirmala Bhoo Pathy, Professor of Epidemiology in the Department of Social and Preventive Medicine at…
Nov 17, 2024, 09:02 | Insight
Breast Cancer - Exposing hidden costs, addressing inequities
ABC Global Alliance shared an article by Prof Charlotte E Coles on LinkedIn: "When the…
Nov 15, 2024, 15:59 | Blog
Shushan Hovsepyan: Can we change the game for sarcoma patients with immunotherapy?
Shushan Hovsepyan shared on LinkedIn: "Can we change the game for sarcoma patients with immunotherapy? Two…
Nov 14, 2024, 15:58 | Insight
Iván R. González: Warning on Sotorasib Treatment for Advanced Lung Cancer
Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared on X:…
Nov 9, 2024, 10:21 | Blog
Toni Choueiri: Our recent perspective on the next therapies in immuno-oncology trials
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, posted…
Nov 8, 2024, 13:58 | Blog
Rashad Nawfal: Our work on the landscape of subsequent therapies in perioperative Immuno-oncology trials
Rashad Nawfal, Postdoctoral Research Fellow at Dana Farber Cancer Institute, shared on X about recent…
Nov 7, 2024, 14:53 | Career
Rana McKay - Candidate for ASCO Nominating Committee
Rana McKay has been nominated as the Undesignated Member Candidate of the nomination committee for…
Nov 6, 2024, 12:05 | Blog
Karl Semaan: Landscape of subsequent therapies in perioperative immunotherapy trials
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, posted on X about recent…
Oct 31, 2024, 09:13 | Blog
Stella Arakelya: Benefits of Holistic Assessment-Based Interventions
Stella Arakelya, Research Fellow at Usher Institute, The University of Edinburg, shared a post by…
Oct 23, 2024, 14:03 | Blog
Gerry Hanna: Latest output from The Early Breast Cancer Trialists' Collaborative Group
Gerry Hanna, Radiation Oncologist at St James's Hospital, shared a post on X: ''Latest output from…
Oct 22, 2024, 23:21 | Blog
Isabel Mestres: Take action to address gender equity in cancer care
Isabel Mestres shared an article on LinkedIn: ''Take action to address gender equity in cancer…
Oct 22, 2024, 17:56 | Blog
Shushan Hovsepyan: Wonderful presentation by Dr. Alexandra Müller about the SAFER Ukraine
Shushan Hovsepyan posted the following on LinkedIn: “Wonderful presentation by Dr. Alexandra Müller about the…
Oct 19, 2024, 12:22 | Blog
Elisa Agostinetto: EBCTCG analysis showing a major in recurrence rates for breast cancer clinical trials between 1990-2009
Elisa Agostinetto shared a post on X: ''Out in The Lancet an EBCTCG analysis showing…
Oct 17, 2024, 18:49 | Blog
Rebecca Shatsky: Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009
Rebecca Shatsky shared a post on X, about recent paper published in The Lancet: Reductions…
Oct 17, 2024, 18:06 | Insight
Paolo Tarantino: We cure breast cancer every day better
Paolo Tarantino shared a post on LinkedIn: "The latest EBCTCG meta-analysis of over 150.000 patients…
Oct 16, 2024, 08:04 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Oct 15, 2024, 10:33 | Blog
Elisabetta Bonzano: Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:…
Oct 15, 2024, 00:34 | Blog
Bishal Gyawali: 15 most FAQs about surrogate endpoints in oncology
Bishal Gyawali shared a post by Oncology News Central on X, adding: "My new piece in Oncology…
Oct 14, 2024, 15:14 | Drugs
Toni Choueiri: Talazoparib with or without enzalutamide in mCRPC
Toni Choueiri shared on X: ''JUST IN: HUGE NEWS ==> OS benefit from TALAPRO-2 study…
Oct 13, 2024, 10:47 | Insight
Melvin L.K. Chua: The massive disparities in global radiotherapy demands
Melvin L.K. Chua shared a post on X: "This is excellent work led by Hongcheng…
Oct 12, 2024, 14:31 | Insight
Ben Ponvilawan: HCC Etiology's Impact on Positive Results in the CARES-310 Trial
Ben Ponvilawan, Doctor of Medicine at UMKC Internal Medicine Residency Program, shared on X: ''…
Oct 8, 2024, 13:52 | Insight
Strategies beyond the WHO Framework Convention on Tobacco Control could reduce deaths due to lung cancer - IARC
IARC - International Agency for Research on Cancer / WHO shared a post on LinkedIn:…
Oct 8, 2024, 12:53 | Blog
Health-care workers in fragile and conflict-ridden contexts - The Institute of Cancer and Crisis
The Institute of Cancer and Crisis shared on LinkedIn about recent paper by Patricia St…
Oct 4, 2024, 19:20 | Blog
The Lancet Oncology Commission presented at ASTRO24 - ESTRO
ESTRO shared a post on LinkedIn: ""An optimized and cost-effective radiotherapy approach could extend treatment to…
Oct 3, 2024, 17:40 | Blog
Honoring Dr Stella Arakelyan and welcoming Dr Mark Lawler as ICC's New Research Lead
The Institute of Cancer and Crisis (ICC) shared a post on LinkedIn, adding: " On…
Sep 30, 2024, 19:23 | Insight
Erman Akkus: Microplastics in prostate tumor and para-tumor
Erman Akkus shared a post on LinkedIn: "Microplastics in prostate tumor and para-tumor 22 matched samples.…
Sep 30, 2024, 17:09 | Insight
Khalid El Bairi: Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement
Khalid El Bairi shared an article on LinkedIn: "Happy to share our second paper in…
Sep 23, 2024, 19:01 | Blog
Ophira Ginsburg: Fantastic week in Geneva with colleagues and friends from near and far
Ophira Ginsburg shared a post on X: "It’s a wrap!! Fantastic week in Geneva with colleagues…
Sep 23, 2024, 16:38 | Blog
Miriam Mutebi: Day 3 of WCC2024 focused on women, HIV and cervical cancer
Miriam Mutebi shared a post on LinkedIn: ''Day 3 of the World Cancer Congress 2024 (WCC2024).…
Sep 18, 2024, 06:20 | Blog
Toni Choueiri: Results from TiNivo2 are out at ESMO24 and The Lancet
Toni Choueiri shared a post on X: "Results from TiNivo2 are out both ESMO24 and…
Sep 17, 2024, 15:03 | Blog
Vivek Subbiah: Now that we have landed in the moon off to Mars
Vivek Subbiah shared a post on X: ''To the moon! Huge congratulations to Toni Choueiri…
Sep 17, 2024, 00:37 | Blog
Raymond Chan: Supportive cancer care 2030 ambitions published in The Lancet’s eClinicalMed
Raymond Chan, Deputy Vice-Chancellor (Research) at Flinders University, posted the following on LinkedIn: “Our The Multinational…
Sep 15, 2024, 16:26 | Societies
43 Posts Not To Miss From ESMO24 Day 2
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 7, 2024, 10:22 | Insight
Adding 6 months of androgen deprivation therapy to post-operative radiotherapy for prostate cancer
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn about a recent…
Sep 5, 2024, 07:07 | Insight
Saarang Deshpande on serum ferritin thresholds for iron deficiency and iron deficiency anemia
Saarang Deshpande shared on X: "As it is a global health issue reflective of health…
Aug 29, 2024, 21:18 | Blog
Miriam Mutebi: Fewer than one radiotherapy machine per million people - a heartbreaking scenario common across Africa
Miriam Mutebi shared on LinkedIn: ""It's not what I want, but let me just have a…
Aug 26, 2024, 17:19 | Blog
Improving cancer care in these challenging setting - Global Coalition for Radiotherapy
Global Coalition for Radiotherapy shared a post on LinkedIn: " RADIOTHERAPY NEWS "The first Global Summit on…
Aug 25, 2024, 09:35 | Blog
Mark Lawler protecting all cancer patients in war-torn regions
Mark Lawler shared a post by Union for International Cancer Control, on X : "On World Humanitarian…
Aug 23, 2024, 14:33 | Insight
Mark Lawler: Our Cancer in Conflict Manifesto
Mark Lawler shared on X: "Some month: Our Cancer in Conflict Manifesto in The Lancet.…
Aug 20, 2024, 14:53 | Blog
Miriam Mutebi: How we can embrace community-centered palliative care that reflects African values and realities
Miriam Mutebi shared on LinkedIn: "This weekend I spent some time thinking about how we…
Aug 19, 2024, 17:01 | Blog
Lena Mkrtchyan: Proud to be part of OncoDaily
Lena Mkrtchyan, YSMU Graduate and Content Curator at OncoDaily.com, shared a post on LinkedIn by…
Aug 19, 2024, 11:58 | Insight
Françoise Meunier on the financial discrimination faced by 20 million cancer survivors across Europe
Françoise Meunier shared a post on LinkedIn: “A new study published today in The Lancet…
Aug 18, 2024, 15:24 | Blog
Aruni Ghose: The Best Team that I’ve worked with when it comes to Cancer Reach and Coverage
Aruni Ghose shared a post on LinkedIn by Gevorg Tamamyan adding: "This is hands down…
Aug 16, 2024, 15:47 | Blog
Maite Bourlon: Leading Oncology Care with Compassion and Innovation
Maite Bourlon posted on X: "Thanks The Lancet for highlighting the work of oncology researchers…
Aug 14, 2024, 08:44 | Blog
Read an article in The Lancet on improving cancer care in conflict-impacted populations - ASCO
ASCO shared on X: "Read an article in The Lancet by our CMO Julie Gralow et…
Aug 9, 2024, 18:04 | Insight
Meyer May-Lucie: New publication in The Lancet reviewing the treatment of advanced lung cancer
Meyer May-Lucie, Doctor at Gustave Roussy, shared on X about a recent paper titled "New…
Aug 7, 2024, 14:42 | Blog
Nazik Hammad: Our manifesto had a good representation from Africa but there is little focus on plight of cancer patients
Nazik Hammad shared on X: "Our manifesto published in the Lancet on August 3rd, on…
Aug 6, 2024, 11:47 | Drugs
FDA Grants Accelerated Approval to Afamitresgene Autoleucel (TECELRA) for Treating Advanced Synovial Sarcoma
On August 2, 2024, the FDA made history by granting accelerated approval to afamitresgene autoleucel…
Aug 5, 2024, 12:59 | Blog
It's not only in Gaza and Ukraine - cancer services in long-term conflict settings - European Cancer Organisation
European Cancer Organisation shared on LinkedIn: "It's not only in Gaza or Ukraine. Today dozens…
Aug 5, 2024, 07:48 | Insight
Maria Babak: Happy to announce our second paper on recommendations to improve cancer care in regions affected by conflict
Maria Babak shared on LinkedIn: "I am happy to announce our second paper in The…
Aug 4, 2024, 12:50 | Blog
Differences in cancer rates among adults born between 1920 and 1990 in the USA
Cathy Eng posted on X about recent paper by Hyuna Sung et al., titled "Differences…
Aug 4, 2024, 11:08 | Blog
Christos Tsagkaris: The manifesto on improving cancer care in conflict-impacted populations
Christos Tsagkaris, Social Media Editor at JBI Evidence Implementation, shared a post on LinkedIn: "The…
Aug 4, 2024, 10:51 | Insight
Jemma Arakelyan: Important Manifesto after the first Global Summit on War and Cancer organized by ICC and OncoDaily
Jemma Arakelyan shared on LinkedIn: "It took us 8 months to publish this important Manifesto…
Aug 4, 2024, 06:50 | Blog
Maria Babak: The Babak Lab weekly digest highlights how developments can transform patient outcomes and broaden treatment possibilities
Maria Babak, Assistant Professor at City University of Hong Kong, shared a post by The…
Aug 2, 2024, 09:38 | OncoDaily Pulse
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Press Release First Global Summit on War and Cancer Develops Key Manifesto to Improve Cancer…
Jul 29, 2024, 10:25 | Blog
Gevorg Tamamyan: The most important thing about OncoDaily
Gevorg Tamamyan shared a post on LinkedIn: ''A few days ago, I discovered something important…
Jul 27, 2024, 13:03 | Blog
Yakup Ergün: Can we truly label a study with Grade 5 toxicity as 'acceptable' or 'manageable'?
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Can we truly label…
Jul 21, 2024, 15:58 | Blog
Shushan Hovsepyan: Highlights from the ARST1431 study about treatment outcomes of RMS patients
Shushan Hovsepyan shared a post on LinkedIn: ''How can we better use molecular insights to…
Jul 21, 2024, 09:13 | Insight
Sumanta K. Pal: Excellent review on kidney cancer from Tom Powles
Sumanta K. Pal shared on X a recent paper by Matthew Young et al. titled…
Jul 19, 2024, 22:19 | Insight
Yüksel Ürün: Congratulations all new participants of the ASCO Leadership Development Program!
Yüksel Ürün shared a post by Miriam Knoll, on X, adding: "Congratulations to you and…
Jul 19, 2024, 06:53 | Blog
Part of the Lancet Discovery Science about the SIOP Europe Annual Meeting 2024 in Milan
SIOP Europe, the European Society for Paediatric Oncology (SIOPE) shared a post on LinkedIn: "Have…
Jul 14, 2024, 07:38 | Insight
Pediatric cancers and family financial toxicity in the Philippines
Edward Christopher Dee, Resident Physician in Radiation Oncology at Memorial Sloan Kettering Cancer Center, shared…
Jul 12, 2024, 11:37 | Insight
More than 30 million people may be diagnosed with cancer in 2040 - The Lancet
The Lancet posted on LinkedIn: "Projections suggest more than 30 million people may be diagnosed…
Jul 12, 2024, 07:47 | Blog
Potential breakthrough for patients with relapsed or refractory large B-cell lymphoma - Parker Institute for Cancer Immunotherapy
Yan Leyfman, Co-Founder and Executive Director at MedNews Week,  shared a posted by Parker Institute…
Jul 9, 2024, 01:25 | Blog
Annual essay competition, the Wakley Prize by The Lancet
The Lancet shared a post on LinkedIn: ''Submission alert - we’re now inviting entries to…
Jul 6, 2024, 23:07 | Blog
IARC has evaluated the carcinogenicity of talc and of acrylonitrile
IARC - International Agency for Research on Cancer shared on LinkedIn: "IARC has evaluated the…
Jul 6, 2024, 10:11 | Insight
Zainab Shinkafi-Bagudu: Great to see the team Cancer Survival Group leading a new The Lancet commission
Zainab Shinkafi-Bagudu shared a post on X: “Great to see the team Cancer Survival Group leading…
Jul 6, 2024, 09:58 | Insight
Justin Ferdinandus: BrECADD is better tolerated than eBEACOPP for patients with advanced Hodgkin Lymphoma
Justin Ferdinandus, Resident Physician at University Hospital Cologne, shared on X: “HD21 results now finally published…
Jul 5, 2024, 01:33 | Blog
Aruni Ghose: A MUST READ - penned down by Mona Hassan and Akash Maniam
Aruni Ghose shared a post by Akash Maniam, Medical Oncologist at Portsmouth Hospitals University NHS…
12
All: 156 Posts: 1 - 100
Special Coverage